BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1328386)

  • 1. Four cell-secreted cytokines act synergistically to maintain long term proliferation of human B cell lines in vitro.
    Abken H; Fluck J; Willecke K
    J Immunol; 1992 Oct; 149(8):2785-94. PubMed ID: 1328386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay.
    Tucci A; James H; Chicheportiche R; Bonnefoy JY; Dayer JM; Zubler RH
    J Immunol; 1992 May; 148(9):2778-84. PubMed ID: 1315359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
    Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
    J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.
    Dett CA; Gatanaga M; Ininns EK; Cappuccini F; Yamamoto RS; Granger GA; Gatanaga T
    J Immunol; 1991 Mar; 146(5):1522-6. PubMed ID: 1847164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human lymphocyte transformation after immortalization by transfection with cytoplasmic DNA from mouse L cells of the cytokines IL-1alpha, IL-6 and TNF].
    Abken H; Fluck J; Willecke K
    Verh Dtsch Ges Pathol; 1990; 74():381-5. PubMed ID: 1708621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyclonal B cell activation induced by herpesvirus saimiri-transformed human CD4+ T cell clones. Role for membrane TNF-alpha/TNF-alpha receptors and CD2/CD58 interactions.
    Del Prete G; De Carli M; D'Elios MM; Fleckenstein IM; Fickenscher H; Fleckenstein B; Almerigogna F; Romagnani S
    J Immunol; 1994 Dec; 153(11):4872-9. PubMed ID: 7525717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and regulation of interleukin 6 in human B lymphoid cells.
    Hutchins D; Cohen BB; Steel CM
    Eur J Immunol; 1990 May; 20(5):961-8. PubMed ID: 2113479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha and interleukin 6 synergistically induce T cell growth.
    Kuhweide R; Van Damme J; Ceuppens JL
    Eur J Immunol; 1990 May; 20(5):1019-25. PubMed ID: 2358016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma.
    Sanceau J; Wijdenes J; Revel M; Wietzerbin J
    J Immunol; 1991 Oct; 147(8):2630-7. PubMed ID: 1918983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines.
    Totpal K; Aggarwal BB
    Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha and IL-6 up-regulate IFN-gamma receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms.
    Sanceau J; Merlin G; Wietzerbin J
    J Immunol; 1992 Sep; 149(5):1671-5. PubMed ID: 1387149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of interleukin 1 and tumour necrosis factor alpha as endogenous growth factors in human osteoblastic cells.
    Modrowski D; Godet D; Marie PJ
    Cytokine; 1995 Oct; 7(7):720-6. PubMed ID: 8580382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
    Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
    J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.
    Arnold R; Humbert B; Werchau H; Gallati H; König W
    Immunology; 1994 May; 82(1):126-33. PubMed ID: 7519169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
    Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.